Connection

GABRIEL HABIB to Calcium Channel Blockers

This is a "connection" page, showing publications GABRIEL HABIB has written about Calcium Channel Blockers.
Connection Strength

0.411
  1. Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality. Clin Ther. 1997; 19 Suppl A:39-52.
    View in: PubMed
    Score: 0.137
  2. Are calcium antagonists harmful in hypertensive patients? Distinguishing hype from reality. Chest. 1995 Jul; 108(1):3-5.
    View in: PubMed
    Score: 0.123
  3. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res. 1986 Feb; 58(2):305-9.
    View in: PubMed
    Score: 0.064
  4. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005 Apr 06; 293(13):1595-608.
    View in: PubMed
    Score: 0.061
  5. Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension. 2013 May; 61(5):977-86.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.